Why the study?
There is a lack of conclusive scientific data on cardiac involvement after COVID-19 infection in athletes and how to safely manage their return to play.
How should athletes be evaluated after COVID-19 infection to ensure a safe return to play?
How should athletes be evaluated after COVID-19 infection to ensure a safe return to play?
This position statement provides a roadmap for the cardiovascular evaluation of athletes post-COVID-19 to balance safe return to play with the prevention of sports-triggered arrhythmias.
Endorses tailored post-COVID screening in athletes to guide safe return to play; extends consensus by limiting CMR to suspected myocarditis and avoiding routine troponin.
The Coronavirus-19 disease (COVID-19) related pandemic have deeply impacted human health, economy, psychology and sociality. Possible serious cardiac involvement in the infection has been described, raising doubts about complete healing after the disease in many clinical settings. Moreover, there is the suspicion that the vaccines, especially those based on mRNA technology, can induce myopericarditis. Myocarditis or pericarditis related scars can represent the substrate for life-threatening arrhythmias, triggered by physical activity. A crucial point is how to evaluate an athlete after a COVID-19 infection ensuring a safe return to play without increasing the number of unnecessary disqualifications from sports competitions. The lack of conclusive scientific data significantly increases the difficulty to propose recommendations and guidelines on this topic. At the same time, the psychological and physical negative consequences of unnecessary sports restriction must be taken into account. The present document aims to provide an updated brief review of the current knowledge about the COVID-19 cardiac involvement and how to recognize it and to offer a roadmap for the management of the athletes after a COVID-19 infections, including subsequent impact on exercise recommendations. Our document exclusively refers to cardiovascular implications of the disease, but pulmonary consequences are also considered.
No takes yet. Share an insight, caveat, or question.
Castelletti et al. (2022) conducted a review in COVID-19 infection in athletes. Cardiovascular screening was evaluated. Tailored cardiovascular screening for athletes after COVID-19 is recommended, reserving cardiac magnetic resonance for suspected myocarditis and advising against systematic troponin testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: